Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates
- 1 November 1998
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 32 (3), 177-183
- https://doi.org/10.1016/s0732-8893(98)00118-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.Journal of Antimicrobial Chemotherapy, 1997
- Teicoplanin resistance in Staphylococcus haemolyticus, developing during treatmentJournal of Antimicrobial Chemotherapy, 1997
- Antimicrobial Resistance in Isolates from Inpatients and Outpatients in the United States: Increasing Importance of the Intensive Care UnitClinical Infectious Diseases, 1997
- Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibioticsJournal of Bacteriology, 1996
- Comparison of an improved RAPD fingerprinting with different typing methods for discriminating clinical isolates of Staphylococcus spp.European Journal of Epidemiology, 1996
- Predominant pathogens in hospital infectionsJournal of Antimicrobial Chemotherapy, 1992
- From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverThe Journal of Infectious Diseases, 1990
- Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticusAntimicrobial Agents and Chemotherapy, 1989
- Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic?JAMA, 1987
- Anti-Staphylococcal Activity of Teicoplanin, Vancomycin, and Other Antimicrobial Agents: The Significance of Methicillin ResistanceThe Journal of Infectious Diseases, 1986